BIO Asia–Taiwan 2021 亞洲生技大會

BIO Asia–Taiwan 2021 亞洲生技大會

講師

Natasha Lai

Session 12 – Recent Development of Game-Changing Tumor Agnostic Therapeutics

Date:23 July (Friday)
Time:  12:20 – 13:50 (GMT+8)

Natasha Lai

Market Access & External Affairs Director
Merck Sharp & Dohme (I.A.) LLC, Taiwan Branch

Natasha is the Director of Market Access and External Affairs at MSD Taiwan. Her focus is on realizing the value of innovation of MSD’s portfolio of game changers in oncology, vaccines, hospital acute care, and general medicine through expediting access to patients in need.
 
Prior to joining MSD, Natasha was the Director of Corporate Affairs and Market Access at Eli Lilly and Company, Taiwan. She had developed her keen interest in pharmaceutical market access through a rotation of commercial roles in new product planning, marketing and market research.
 
Natasha received her bachelor's degree in Political Science from Bryn Mawr College and Diploma in Government from the London School of Economics. She is legally trained at the National Taiwan University College of Law.